Altimmune CEO on what’s next for its experimental obesity drug
0
0
04/12/24
Dans
Amérique du Nord / États-Unis
Vipin Garg, Altimmune CEO, joins 'Fast Money' to discuss Altimmune announcing topline results from its obesity drug trial, potential commercial partnership and more.
Montre plus
0 commentaires
sort Trier par
